Skip to main content
EVGN
NASDAQ Industrial Applications And Services

Activist Group Rejects Settlement, Raises Stake to 17.41%, and Sets July 31 Deadline for Board Overhaul

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.558
Mkt Cap
$6.566M
52W Low
$0.37
52W High
$1.5
52W Position info
51% above low
Off High info
63% below high
Rel. Volume
Market data snapshot near publication time

EVGN sits 51% above its 52-week low of $0.37.

Summary

The activist group demanding a board overhaul at Evogene rejected a settlement offer, bought more shares to reach 17.41% ownership, and set a July 31 deadline for the company to call a special meeting — intensifying the proxy battle.


Key Events · Ownership and Investor Activity · EVGN

  • Settlement Rejected, Deadlines Set

    The activist group rejected the board's offer of a single seat and demanded the special meeting be called by July 31, 2026, with the meeting held by September 4, 2026. It also requested draft proxy materials by July 28.

  • Stake Increased to 17.41%

    Pure Capital bought 80,000 ADSs at $0.579 on July 20, 2026, raising the group's aggregate ownership to 2,308,100 shares (17.41% of outstanding).

  • Warning Against Extraordinary Actions

    The group warned the board not to take any actions outside the ordinary course of business before the special meeting, citing potential conflicts of interest.

  • Proxy Fight Intensifies

    This is the third 13D filing in 17 days, showing an escalating activist campaign against a backdrop of a $3.3M ATM offering and a terminated Bayer partnership.


Analysis · EVGN · Industrial Applications And Services

The activist group seeking to replace Evogene's board has escalated its campaign. It rejected the company's settlement offer of a single board seat, demanded the board call a special meeting by July 31, and warned against any extraordinary corporate actions before then. The group also bought 80,000 more shares, lifting its stake to 17.41%. This hardens the proxy fight and raises the stakes for the upcoming special meeting, which could reshape the company's strategy amid a cash crunch and ongoing ATM dilution.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EVGN was trading at $0.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.6M. The 52-week trading range was $0.37 to $1.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Nov 16, 2026, 7:01 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3646
Real-time Price: $0.3764 info
Change: +$0.0118 (+3%) info
Market Cap: $6.653M info
EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.3764 info
Change: -$0.0337 (-8%) info
Market Cap: $6.653M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.3764 info
Change: -$0.0404 (-10%) info
Market Cap: $6.653M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.3764 info
Change: -$0.0143 (-4%) info
Market Cap: $6.653M info
EVGN
Sep 15, 2026, 5:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.5281
Real-time Price: $0.3764 info
Change: -$0.1517 (-29%) info
Market Cap: $6.653M info